International Clinical Trial: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II/III Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07454720) titled 'A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II/III Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer' on Feb. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Condition: Locally Advanced Resectable Rectal Cancer

Intervention: Drug: Adebrelimab in combination with SHR-8068 and chemotherapy Drug: Adebrelimab combined with che...